Search - tctmd.com

Displaying 1 - 20 of 44

Sort: Relevancy | Date

News Daily News

尽管没有随机对照试验，但倾向得分匹配分析为导管室选择坎格雷洛和GPI提供了指导

Yael L. Maxwell

December 06, 2016

News Daily News

With No RCTs, Propensity-Score Matched Analysis Informs Choice Between Cangrelor and GPIs in the Cath Lab

Yael L. Maxwell

December 06, 2016

News Daily News

Sin ECA, el Análisis de Emparejamiento por Puntuación de la Propensión permite tomar una Decisión Informada entre Cangrelor y GPI en el Laboratorio de Cateterización

Yael L. Maxwell

December 06, 2016

News Conference News ESC 2016

Day or Night, STEMI Patients Receive Similar Levels of Quality Care

August 31, 2016

“Off Hours” Versus “On Hours” Presentation in ST-Segment Elevation Myocardial Infarction: Findings from CHAMPION PHOENIX

Presentation ESC 2016

“Off Hours” Versus “On Hours” Presentation in ST-Segment Elevation Myocardial Infarction: Findings from CHAMPION PHOENIX

Presenter: Deepak L. Bhatt

August 31, 2016

News Opinion Conversations in Cardiology

Conversations in Cardiology: Post-PCI Clopidogrel in CHAMPION PHOENIX Trial of Cangrelor

February 08, 2016

TCT 79: Efficacy of Cangrelor in Lesions With High-Risk and Low-Risk Angiographic Characteristics The CHAMPION PHOENIX Trial

Presentation TCT 2015

TCT 79: Efficacy of Cangrelor in Lesions With High-Risk and Low-Risk Angiographic Characteristics The CHAMPION PHOENIX Trial

Presenter: Lisa K. Jennings, Neal S. Kleiman, Gregg W. Stone

October 13, 2015

TCT 75: Cangrelor Improves Ischemic Outcomes in Patients With Multivessel Disease and Single Vessel Disease Undergoing PCI Insights From the CHAMPION PHOENIX Trial

Presentation TCT 2015

TCT 75: Cangrelor Improves Ischemic Outcomes in Patients With Multivessel Disease and Single Vessel Disease Undergoing PCI Insights From the CHAMPION PHOENIX Trial

Presenter: Lisa K. Jennings, Neal S. Kleiman, Freddy Abnousi

October 13, 2015

News Conference News TCT 2015

Experts Debate Optimal Pharmacologic Approach for STEMI Patients

October 11, 2015

News Daily News

在PCI患者中切入部位和坎格雷洛之间没有相互作用

October 06, 2015

News Daily News

No Interplay Between Access Site, Cangrelor Effects in PCI Patients

October 06, 2015

News Daily News

No hay interacción entre el punto de acceso y los efectos del Cangrelor en pacientes con PCI

October 06, 2015

CHAMPION PHOENIX: Effect of Cangrelor and Access Site on Ischemic and Bleeding Events

Presentation

CHAMPION PHOENIX: Effect of Cangrelor and Access Site on Ischemic and Bleeding Events

Presenter: JA. Gutierrez

October 05, 2015

News Industry News

The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin)

July 09, 2015

News Daily News

La Aprobación de la FDA de Cangrelor Amplía las Opciones Antiplaquetarias para la PCI

June 29, 2015

News Daily News

FDA 批准坎格雷洛作为 PCI 的抗血小板治疗方案

June 29, 2015

News Daily News

FDA Approval of Cangrelor Expands Antiplatelet Options for PCI

June 29, 2015

News Daily News

Un Panel de la FDA Avala Cangrelor para ser Utilizado en PCI

April 29, 2015

News Daily News

FDA Panel Backs Cangrelor for Use in PCI

April 29, 2015

News Daily News

Study Quantifies Costs Arising From Thrombotic Events During PCI for NSTE-ACS

April 09, 2015

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.